About 8 results found for searched term "92-84-2" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2936 | Phenothiazine | Dopamine Receptor |
| Phenothiazine is a dopamine-2 (D2) receptor antagonist therefore decreases the effect of dopamine in the brain. | ||
| M30492 | (R)-TAPI-2 | Others |
| (R)-TNF Protease Inhibitor 2 | ||
| (R)-TAPI-2 is the isomer of TAPI-2. TAPI-2 (TNF Protease Inhibitor 2) is a broad-spectrum inhibitor of matrix metalloprotease (MMP), tumour necrosis factorα-converting enzyme (TACE) and a disintegrin and metalloproteinase (ADAM), with an IC50 of 20 μM for MMP. TAPI-2 blocks the entry of infectious SARS-CoV. | ||
| M40947 | Inotersen | Transthyretin (TTR) |
| GSK-2998728; ISIS-420915 | ||
| Inotersen is an antisense oligonucleotide that inhibits the production of the hepatic transthyretin (TTR) protein. It can be used in studies related to TTR-mediated amyloidosis. | ||
| M44494 | Gambogic acid A | Others |
| Gambogic acid A | ||
| M3802 | GF 109203X | PKC |
| GO 6850 | ||
| GF 109203X is a very potent and selective inhibitor of protein kinase C, selective for the α and β1 isoforms (IC50 values are 0.0084, 0.0180, 0.210, 0.132, and 5.8 μM for α, β1, δ, ε and ζ isoforms respectively). | ||
| M13723 | GW1929 | PPAR |
| GW1929 is a potent PPAR-γ agonist, with a pKi of 8.84 for human PPAR-γ, and pEC50s of 8.56 and 8.27 for human PPAR-γ and murine PPAR-γ, respectively. | ||
| M29631 | BC-DXI-843 | Others |
| BC-DXI-843 is a potent and specific AIMP2-DX2 inhibitor with an IC50 of 0.92 μM, more than 100-fold selectivity over AIMP2 (IC50 >100 μM) in a luciferase assay. BC-DXI-843 acts as a promising lead targeting AIMP2-DX2 in lung cancer. | ||
| M31081 | PF-07284892 | Phosphatase |
| ARRY-558 | ||
| PF-07284892 (ARRY-558) is a potent and orally activity SHP2 inhibitor with an IC50 value of 21 nM. PF-07284892 decreases theexpression of pERK. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
